Next, the methylation status of candidate genes was associated with known clinicopathologic characteristics, including age at blood sampling, tumor grade, tumor size, node status, ER, PR status, tumor subtype, location of metastases and number of metastatic sites. This evidence concerns the gene ESR1 and neoplasm.